US 10822429
Etanercept formulations exhibiting marked reduction in sub-visible particles
granted A61KA61K2039/505A61K38/1793
Quick answer
US patent 10822429 (Etanercept formulations exhibiting marked reduction in sub-visible particles) held by Coherus BioSciences, Inc. expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K38/1793, A61K47/02, A61K47/10